Mechanistically, ChIV treatment significantly alleviated sevoflurane-induced apoptotic cell and neuroinflammation. Of note, the neuroprotective effect of ChIV against sevoflurane-induced neurotoxicity through blocking NLRP3/caspase-1 pathway. In consistent with in vivo studies, ChIV was also able to repress sevoflurane-induced apoptosis and neuroinflammation in primary neurons. Furthermore, pretreatment with NLRP3/caspase-1 pathway inhibitor (MCC950) significantly augmented the neuroprotective effect of ChIV. CONCLUSION Our finding confirmed that ChIV provides a neuroprotective effect against sevoflurane-induced neuroinflammation and cognitive impairment by blocking the NLRP3/caspase-1 pathway, which may be an effective strategy for the clinical treatment of elderly patients with POCD induced by anesthesia.BACKGROUND To bridge the knowledge gap, the present study aimed to investigate the effect of different doses of two widely used performance-enhancing drugs 'methamphetamine' (Meth) and 'human chorionic gonadotropin'(hCG) on ex-vivo cultured primary blood cells of young male Indian athletes. METHODS Primary blood mononuclear cells (PBMCs) were isolated and cultured to obtain pure T cells and monocyte-derived macrophages. Immunofluorescence, flow-cytometry, qRT-PCR, Western blot, ELISA and siRNA transfection studies were carried out to evaluate the effect of these two drugs on athletes' blood cells. RESULTS Cell viability studies revealed that Meth at high doses was toxic for PBMCs and showed a significant negative impact on red blood cell fragility but hCG incubation did not result in any cytotoxicity or haemolysis. The current study also demonstrated that Meth incubation significantly affected T cell proliferation, percentage of regulatory T cells (Treg cells), Th17 cells, early activated T cells, ROS generation and mitochondrial dysfunction. On the other hand, hCG treatment upregulated the percentage of Treg cells. Within macrophage cells, Meth incubation upregulated MYD88 dependent TLR4 pathway and decreased the phagocytotic capability of the cells. Both hCG and Meth showed its potential action on alteration the pro/anti-inflammatory cytokine profiling but suppression of TLR4 pathway by RNA interference (TLR4 siRNA) suggested promising future treatment modalities. CONCLUSION This study demonstrated the differential effects of Meth and hCG on immune cells of athlete's blood. Meth acted as an inflammation and T cell dysfunction inducing agent, while hCG acted as an anti-inflammatory immunosuppressive molecule.BACKGROUND High level of comorbidity between bipolar disorder or schizophrenia and cardiovascular diseases (CVD) in clinical practice may contribute to drug-drug interactions between medications used in these conditions. The aim of this study was to evaluate harmful interactions between antipsychotics and medications used in treatment of CVD. METHODS The analysis of 52 cases of adverse reactions with a clinical picture indicates that they were the result of the combination of antipsychotic with cardiovascular medications. RESULTS The highest number of interactions with antipsychotics was recorded among beta-blockers (n?=?13, 25% of all cases), including cardiac arrhythmias [atrial fibrillation (n?=?1) risperidone plus atenolol; bradycardia (n?=?1) perphenazine with metoprolol; ventricular arrhythmias sertindole with metoprolol (n?=?1) and ziprasidone with sotalol (n?=?3)] and hypotension [chlorprotixene with nebivolol or metoprolol (n?=?2)]. 12 cases concerned statins-myalgia, myopathy, or creatine kinase elevation appeared after combination of atorvastatin with haloperidol (n?=?1), quetiapine (n?=?3) or risperidone (n?=?1), and simvastatin with quetiapine (n?=?5) or risperidone (n?=?2). There were also cases of interactions observed for the use of antipsychotics with anti-arrhythmic drugs (amiodarone, flecainide, propafenone) (n?=?11), calcium channel blockers (n?=?6), and other cardiac medications clonidine, dabigatran, doxazosin, ivabradine, and losartan (n?=?10). CONCLUSIONS Due to a high risk of interactions and related adverse effects, particular attention should be paid while using cardiovascular medications with antipsychotics. Clinical decisions should be preceded by a detailed analysis of safety, risk-benefit ratio to search for, as safe as possible, drug combinations.BACKGROUND Psoriasis is a multifactorial autoimmune disease, which underlies the abnormalities of the apoptotic process. In cases of psoriasis and psoriatic arthritis, biological treatment is used. This study aimed to determine any changes in the expression of the genes associated with apoptosis in patients with psoriatic arthritis treated with adalimumab and to assess any phenotypic modifications based on changes in dermatological indexes. METHODS The study included 20 patients with psoriatic arthritis treated biologically and 20 healthy volunteers. The research material consisted of peripheral blood mononuclear cells (PBMCs) from which the total RNA was isolated. Changes in the gene expression were determined using oligonucleotide microarrays and RT-qPCR. The clinical condition was assessed based on selected indicators PASI, BSA [%], DAS28, and DLQI, which were determined every 3&nbsp;months. RESULTS There were changes in the expression of genes associated with apoptosis. Significant differences were found for ROCK1, RhoA, and LIMK2 expression profiles in PBMCs. At the initial stage of treatment, a decrease in the PASI and BSA rates was observed. At the later stages, the values of these indicators increased once again. There were correlations between the changes in these genes' expression and the dermatological markers. CONCLUSION Adalimumab influences the expression of genes related to apoptosis and the values of dermatological indicators of patients. Changes in the expression level of genes associated with apoptosis suggest that ROCK1, RhoA, and LIMK2 may be genes that can potentially be indicators of treatment effectiveness and lack of response to biological treatment.BACKGROUND Antagonistic adenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) receptor-receptor interactions have previously been demonstrated in A2AR-D2R heteroreceptor complexes in the rat dorsal striatum. https://www.selleckchem.com/products/ve-822.html They mainly involve a reduction of affinity in the high-affinity component of the D2R agonist binding site upon activation in vivo of the A2AR by an A2AR agonist. Upon cocaine self-administration, this antagonistic A2AR-D2R interaction disappeared in the dorsal striatum. METHODS In the current experiments, it was tested whether such modifications in the antagonistic A2AR-D2R receptor-receptor interactions can develop also after an acute systemic injection of a low cocaine dose (1&nbsp;mg/kg; sc). RESULTS Microdialysis experiments indicated that acute cocaine did not significantly alter the extracellular dopamine levels in the dorsal striatum of the awake Wistar rats. Competition dopamine receptor binding experiments demonstrated that in the acute cocaine group, the A2AR agonist CGS-21680 produced significantly larger increases in the D2R Ki, High values (reduction of high-affinity) versus the saline-injected (i.